Agonist interaction with alkylation-sensitive and -resistant alpha-1 adrenoceptor subtypes

Area of Science:

• Pharmacology
• Molecular Biology
• Cardiovascular Research

Background:

• Alpha-1 adrenergic receptors (α1-ARs) are crucial in regulating vascular tone and exhibit diverse subtypes.
• Understanding the distinct properties and signaling pathways of these subtypes is essential for developing targeted therapeutics.

Purpose of the Study:

• To investigate the interaction of agonists with alpha-1 receptor subtypes sensitive and resistant to alkylation by SZL-49.
• To characterize the affinity, signaling, and functional responses mediated by these distinct α1-AR subtypes.

Main Methods:

• In vitro studies using rat aortic rings to assess agonist dose-response curves and receptor binding.
• In vivo studies evaluating pressor responses to agonists after SZL-49 administration.
• Investigation of inositol phosphate formation and the effects of pertussis toxin.

Main Results:

• SZL-49 selectively eliminated high-affinity phenylephrine binding sites, suggesting it targets a specific α1-AR subtype.
• Both SZL-49-sensitive and -resistant α1-AR subtypes mediate full agonist responses, exhibiting high and low affinities.
• Agonist responses were partially dependent on calcium channel activity and a pertussis toxin-sensitive G-protein.
• SZL-49 inhibited norepinephrine-induced inositol phosphate formation, indicating its role in this signaling pathway.

Conclusions:

• Distinct alpha-1 receptor subtypes, differing in their sensitivity to SZL-49 alkylation and agonist affinity, coexist and mediate physiological responses.
• These subtypes' signaling pathways involve calcium channels and pertussis toxin-sensitive G-proteins.
• The SZL-49 sensitive alpha-1 receptor subtype plays a significant role in enhancing inositol phosphate formation.